These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial. Romagnoli C; Zecca E; Vento G; Maggio L; Papacci P; Tortorolo G Pharmacology; 1999 Nov; 59(5):266-74. PubMed ID: 10529659 [TBL] [Abstract][Full Text] [Related]
8. The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray. Schrod L; Neuhaus T; Horwitz AE; Speer CP Pediatr Radiol; 2001 May; 31(5):332-8. PubMed ID: 11373920 [TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595 [TBL] [Abstract][Full Text] [Related]
10. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Halliday HL; Ehrenkranz RA Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251 [TBL] [Abstract][Full Text] [Related]
12. Lung function and exhaled nitric oxide levels in infants developing chronic lung disease. Williams O; Dimitriou G; Hannam S; Rafferty GF; Greenough A Pediatr Pulmonol; 2007 Feb; 42(2):107-13. PubMed ID: 17186509 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of nitric oxide in chronic lung disease. Clark PL; Ekekezie II; Kaftan HA; Castor CA; Truog WE Arch Dis Child Fetal Neonatal Ed; 2002 Jan; 86(1):F41-5. PubMed ID: 11815547 [TBL] [Abstract][Full Text] [Related]
14. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Shah SS; Ohlsson A; Halliday H; Shah VS Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423 [TBL] [Abstract][Full Text] [Related]
15. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Shah SS; Ohlsson A; Halliday H; Shah VS Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425 [TBL] [Abstract][Full Text] [Related]
16. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease. Seth R; Gray PH; Tudehope DI Neonatology; 2009; 95(2):172-8. PubMed ID: 18776732 [TBL] [Abstract][Full Text] [Related]
17. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Shah V; Ohlsson A; Halliday HL; Dunn MS Cochrane Database Syst Rev; 2000; (2):CD001969. PubMed ID: 10796275 [TBL] [Abstract][Full Text] [Related]
18. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. Groneck P; Reuss D; Götze-Speer B; Speer CP J Pediatr; 1993 Jun; 122(6):938-44. PubMed ID: 8388949 [TBL] [Abstract][Full Text] [Related]
19. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Halliday HL; Ehrenkranz RA Cochrane Database Syst Rev; 2000; (2):CD001146. PubMed ID: 10796252 [TBL] [Abstract][Full Text] [Related]
20. Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease. Mieskonen ST; Malmberg LP; Kari MA; Pelkonen AS; Turpeinen MT; Hallman NM; Sovijärvi AR Pediatr Pulmonol; 2002 May; 33(5):347-55. PubMed ID: 11948979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]